Standout Papers

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy 2019 2026 2021 2023 1.6k
  1. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy (2019)
    Jonathan J. Havel, Diego Chowell et al. Nature reviews. Cancer

Citation Impact

Citing Papers

TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
2017 Standout
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
2017 Standout
Pan-cancer single-cell landscape of tumor-infiltrating T cells
2021 Science
Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression
2021 StandoutNobel
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
2024 StandoutNobel
Reading the glyco-code: New approaches to studying protein–carbohydrate interactions
2022 StandoutNobel
Head and neck squamous cell carcinoma
2020 Standout
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
2020
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
2017 Standout
Roles of the immune system in cancer: from tumor initiation to metastatic progression
2018
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Molecular and histological correlations in liver cancer
2019
Pharmacological targeting of endoplasmic reticulum stress in disease
2021
Hallmarks of aging: An expanding universe
2023 Standout
Hepatocellular carcinoma
2021 Standout
Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
2018
The immune contexture in cancer prognosis and treatment
2017 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Tumour-intrinsic resistance to immune checkpoint blockade
2019
Eicosanoids in Cancer: New Roles in Immunoregulation
2020
Landscape of tumor-infiltrating T cell repertoire of human cancers
2016
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
CD8+ T cell differentiation and dysfunction in cancer
2021
The molecular landscape of head and neck cancer
2018 Standout
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
2020
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Structural Prediction of Peptide–MHC Binding Modes
2022
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
2016 Standout
Macrophages as tools and targets in cancer therapy
2022
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
2020
Glycoproteomics
2022 StandoutNobel
Gold-Loaded Nanoporous Ferric Oxide Nanocubes with Peroxidase-Mimicking Activity for Electrocatalytic and Colorimetric Detection of Autoantibody
2017
Tumor neoantigens: building a framework for personalized cancer immunotherapy
2015
SUGAR-seq enables simultaneous detection of glycans, epitopes, and the transcriptome in single cells
2021
Peptide-binding specificity prediction using fine-tuned protein structure prediction networks
2023 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinoma
2017
HPV, hypoxia and radiation response in head and neck cancer
2018
β-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancer
2020
Therapeutic cancer vaccines
2015

Works of Diego Chowell being referenced

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
2017 Science
HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx
2015
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status
2015
Autoantibody biomarkers for the detection of serous ovarian cancer
2017
TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+T cell epitopes
2015
Rankless by CCL
2026